Chinese english Germany Japanese Korea

5-METHYL-1-(β-L-RIBOFURANOSYL)URACIL

5-METHYL-1-(β-L-RIBOFURANOSYL)URACIL Struktur
642082-80-2
CAS-Nr.
642082-80-2
Englisch Name:
5-METHYL-1-(β-L-RIBOFURANOSYL)URACIL
Synonyma:
L-5-Me-Uridine;L-5-Methyluridine;L-5-Methy-Uridine;Thymine riboside, L-;5-METHYL-1-(β-L-RIBOFURANOSYL)URACIL
CBNumber:
CB21553277
Summenformel:
C10H14N2O6
Molgewicht:
258.229
MOL-Datei:
642082-80-2.mol
Request For Quotation

5-METHYL-1-(β-L-RIBOFURANOSYL)URACIL Eigenschaften

Sicherheit

5-METHYL-1-(β-L-RIBOFURANOSYL)URACIL Chemische Eigenschaften,Einsatz,Produktion Methoden

5-METHYL-1-(β-L-RIBOFURANOSYL)URACIL Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

5-METHYL-1-(β-L-RIBOFURANOSYL)URACIL Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 24)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
career henan chemical co 		+86-0371-86658258 +8613203830695
 sales@coreychem.com China 29850 58
Finetech Industry Limited 		+86-27-8746-5837 +8619945049750
 info@finetechnology-ind.com China 9629 58
BOC Sciences 		16314854226; +16314854226
 inquiry@bocsci.com United States 19654 58
NewCan Biotech Limited 		+86-0571-86912261 +8613735419629
 sales@newcanbio.com China 9985 58
changzhou huayang technology co., ltd 		+8615250961469
 2571773637@qq.com China 9644 58
Wuhu Nuowei chemistry Co., Ltd. 		+86-0553-2911116-802 +86-18055326116
 sales1@nuowei-chem.com China 1627 58
Chemtour Biotech Co., Ltd 		+8617327281506
 market@chemtour.com China 1521 58
PANNACEAN(HENAN)MEDICINE SCIENCE TECHNOLOGIES LTD 		0371-55159968 18137130222
 haifeng.zhang@pannacean.com China 715 58
Shenzhen Nexcon Pharmatechs Ltd. 		+86-0755-89396905 +86-18025329037
 admin@nexconn.com China 3218 58
Chongqing Chemdad Co., Ltd 		+86-023-6139-8061 +86-86-13650506873
 sales@chemdad.com China 39927 58
  • 5-METHYL-1-(β-L-RIBOFURANOSYL)URACIL
  • L-5-Methyluridine
  • L-5-Me-Uridine
  • L-5-Methy-Uridine
  • Thymine riboside, L-
  • 642082-80-2
Copyright 2019 © ChemicalBook. All rights reserved